本文来源 “ 撤稿 资讯 ” 官微
如需了解更多精彩内容请联系
论文信息
2020年7月，广东医科大学附属医院在 OncoTargets and Therapy（IF4.0000 /4区） 期刊上在线发表题为 “Upregulation of FTX Promotes Osteosarcoma Tumorigenesis by Increasing SOX4 Expression via miR-214-5p” （FTX上调通过miR-214-5p增加SOX4表达促进骨肉瘤发生）的论文。
第一作者：广东医科大学附属医院的Haicong Chen（音译 陈海聪），Tianfeng Liu（音译 刘田丰）；通讯作者：广东医科大学附属医院的Huan Zhong（音译 钟环）
撤稿说明
2023年8月10日，期刊在线发表了撤稿说明：
We, the Editors and Publisher of OncoTargets and Therapy, have retracted the published article.
Since publication, concerns have been raised about the integrity of the data in the article. When approached for an explanation, the authors did not respond to our queries, nor did they provide original data for their study. As verifying the validity of the published work is core to the integrity of the scholarly record, we are therefore retracting the article and the authors were notified of this.
We have been informed in our decision-making by our editorial policies and the COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
我们，OncoTargets and Therapy的编辑和出版商，已经撤回了发表的文章。
自发表以来，有人对文章中数据的完整性提出了质疑。当被要求解释时，作者没有回应我们的询问，也没有为他们的研究提供原始数据。由于验证发表作品的有效性是学术记录完整性的核心，因此我们撤回了这篇文章，并通知了作者。
我们的编辑政策和COPE指南为我们的决策提供了信息。
被撤回的文章将保留在网上，以维护学术记录，但它将在每页上添加数字水印，以示“被撤回”。
参考信息：
https://pubpeer.com/publications/C7115438BD1C6CF115372BB32B2998
https://www.dovepress.com/upregulation-of-ftx-promotes-osteosarcoma-tumorigenesis-by-increasing--peer-reviewed-fulltext-article-OTT
https://www.dovepress.com/retraction-upregulation-of-ftx-promotes-osteosarcoma-tumorigenesis-by--peer-reviewed-fulltext-article-OTT
本文来源 “ 撤稿 资讯 ” 官微
如需了解更多精彩内容请联系